NCT00002939 arm group c2c2c36b22bc8b33693644bf58b3d129 [clinicaltrials_resource:NCT00002939/arm-group/c2c2c36b22bc8b33693644bf58b3d129]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00002939 arm group c2c2c36b22bc8b33693644bf58b3d129 [clinicaltrials_resource:NCT00002939/arm-group/c2c2c36b22bc8b33693644bf58b3d129]
Bio2RDF identifier
NCT00002939/arm-group/c2c2c36b22bc8b33693644bf58b3d129
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c2c36b22bc8b33693644bf58b3d129
description [clinicaltrials_vocabulary:description]
The first study cohort will re ...... nd 15 of each treatment cycle.
identifier
clinicaltrials_resource:NCT00002939/arm-group/c2c2c36b22bc8b33693644bf58b3d129
title
NCT00002939 arm group c2c2c36b22bc8b33693644bf58b3d129
@en
type
label
NCT00002939 arm group c2c2c36b ...... 2c36b22bc8b33693644bf58b3d129]
@en